Factors affecting genetic testing and decisions about prophylactic surgery.
1St. Louis University, Division of Hematology/Oncology, St. Louis, MO, USA.
Clinical Journal of Oncology Nursing
|March 20, 2002
Summary
Genetic testing decisions and adjustment to prophylactic surgery require more research. Oncology nurses are key to supporting individuals with high cancer risk due to genetic mutations.
Area of Science:
- Genetics
- Oncology Nursing
- Preventive Healthcare
Background:
- Limited understanding exists regarding genetic testing impacts.
- Decisions, care guidance, and adjustment to prophylactic surgery are unclear.
- Individuals at high genetic cancer risk need comprehensive support.
Purpose of the Study:
- To highlight knowledge gaps in genetic testing and prophylactic surgery.
- To emphasize the role of oncology nurses in patient education and support.
- To call for further nursing research on adjustment to genetic risk and preventive measures.
Main Methods:
- Literature review on genetic testing and prophylactic surgery.
- Analysis of current practices and research limitations.
- Identification of psychosocial needs and nursing care gaps.
Main Results:
- Significant gaps in knowledge about genetic testing decisions and outcomes.
- Uncertainty regarding long-term effectiveness and psychosocial impact of prophylactic surgeries.
- Oncology nurses are well-positioned to provide essential education and support.
Conclusions:
- More research is needed on genetic testing, prophylactic surgery effectiveness, and psychosocial adjustment.
- Oncology nurses play a crucial role in guiding individuals with genetic cancer risk.
- Interventions are required to improve patient adjustment to genetic information and preventive surgeries.
More Related Videos
07:15Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
06:21Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform
Published on: May 10, 2024
Related Concept Videos
02:59Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...